P38 mitogen-activated protein kinase modulates expression of tumor necrosis factor-related apoptosis-inducing ligand induced by interferon-γ in fetal brain astrocytes

被引:31
作者
Lee, J
Shin, JS
Park, JY
Kwon, D
Choi, SJ
Kim, SJ
Choi, IH [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Microbiol, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Brain Korea Project Med Sci 21, Seoul 120752, South Korea
[3] Yonsei Univ, Wonju Coll Med, Dept Microbiol, Seoul 120749, South Korea
关键词
astrocytes; IFN-gamma; p38; kinase; TRAIL;
D O I
10.1002/jnr.10815
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
This study describes the involvement of the p38 mitogen-activated protein kinase (MAPK) during interferon-gamma (IFN-gamma) signaling in fetal brain astrocytes. In some pathological conditions of brain, p38 MAPK transduces stress-related signals, increases expression of proinflammatory cytokines, and induces cellular damage or apoptosis. In astrocytes, the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) expression level was increased by IFN-gamma. AG490, a JAK inhibitor, blocked TRAIL expression induced by IFN-gamma. SB203580, a specific p38alpha and p38beta2 MAPK inhibitor, decreased the TRAIL expression induced by IFN-gamma. The phosphorylation of the Ser727 site of STAT1, but not the Tyr701 site, was inhibited by SB203580. These results suggest that p38 MAPK modulates STAT1 phosphorylation in IFN-gamma signaling in fetal brain astrocytes. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:884 / 890
页数:7
相关论文
共 34 条
[1]
Aloisi F, 1999, J IMMUNOL, V162, P1384
[2]
Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength [J].
Alonso, G ;
Ambrosino, C ;
Jones, M ;
Nebreda, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40641-40648
[3]
Choi C, 1999, J IMMUNOL, V162, P1889
[4]
INDEPENDENT HUMAN MAP KINASE SIGNAL-TRANSDUCTION PATHWAYS DEFINED BY MEK AND MKK ISOFORMS [J].
DERIJARD, B ;
RAINGEAUD, J ;
BARRETT, T ;
WU, IH ;
HAN, JH ;
ULEVITCH, RJ ;
DAVIS, RJ .
SCIENCE, 1995, 267 (5198) :682-685
[5]
Induction of TRAIL-mediated glioma cell death by human T cells [J].
Dörr, J ;
Waiczies, S ;
Wendling, U ;
Seeger, B ;
Zipp, F .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 122 (1-2) :117-124
[6]
Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6 [J].
Enslen, H ;
Raingeaud, J ;
Davis, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1741-1748
[7]
Expression of TRAIL and its receptors in human brain tumors [J].
Frank, S ;
Köhler, U ;
Schackert, G ;
Schackert, HK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (02) :454-459
[8]
Intrathecal delivery of IFN-γ protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes [J].
Furlan, R ;
Brambilla, E ;
Ruffini, F ;
Poliani, PL ;
Bergami, A ;
Marconi, PC ;
Franciotta, DM ;
Penna, G ;
Comi, G ;
Adorini, L ;
Martino, G .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1821-1829
[9]
p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons [J].
Goh, KC ;
Haque, SJ ;
Williams, BRG .
EMBO JOURNAL, 1999, 18 (20) :5601-5608
[10]
Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL [J].
Griffith, TS ;
Wiley, SR ;
Kubin, MZ ;
Sedger, LM ;
Maliszewski, CR ;
Fanger, NA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) :1343-1353